Pharma giants AstraZeneca and Bristol-Myers in reported merger talks

AstraZeneca, Bristol Myers are in talks about merger — report

AstraZeneca & Bristol Myers Squibb in merger talks per Financial Times. AZ worth ~$265B, BMS ~$133B. Deal may involve stock & cash; talks may not lead to deal.